Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2 CAD 1.52% Market Closed
Market Cap: 129.3m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arch Biopartners Inc
Operating Income Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Operating Income
-CA$5.5m
CAGR 3-Years
11%
CAGR 5-Years
-24%
CAGR 10-Years
-33%
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Income
-$237.2m
CAGR 3-Years
N/A
CAGR 5-Years
-212%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Operating Income
-CA$1.4m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Operating Income
-CA$519.1k
CAGR 3-Years
N/A
CAGR 5-Years
-164%
CAGR 10-Years
2%

See Also

What is Arch Biopartners Inc's Operating Income?
Operating Income
-5.5m CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Operating Income amounts to -5.5m CAD.

What is Arch Biopartners Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-33%

Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Arch Biopartners Inc have been 11% over the past three years , -24% over the past five years , and -33% over the past ten years .

Back to Top